These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27215135)

  • 1. Use of ISTH bleeding assessment tool to predict inherited platelet dysfunction in resource constrained settings.
    Rashid A; Moiz B; Karim F; Shaikh MS; Mansoori H; Raheem A
    Scand J Clin Lab Invest; 2016 Sep; 76(5):373-8. PubMed ID: 27215135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders.
    Lowe GC; Lordkipanidzé M; Watson SP;
    J Thromb Haemost; 2013 Sep; 11(9):1663-8. PubMed ID: 23809206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of the international society on thrombosis and hemostasis-bleeding assessment tool in the diagnosis of patients who suspected of platelet function disorders.
    Shahbazi M; Ahmadinejad M; Teimourpour A
    Blood Coagul Fibrinolysis; 2024 Jan; 35(1):8-13. PubMed ID: 37994630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
    Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
    Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance.
    Doherty D; Grabell J; Christopherson PA; Montgomery RR; Coller BS; Lavin M; O'Donnell JS; James PD;
    J Thromb Haemost; 2023 Apr; 21(4):880-886. PubMed ID: 36696194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of International Society on Thrombosis and Haemostasis-Bleeding Assessment Tool and other bleeding questionnaires in assessing the bleeding phenotype in two platelet function defects.
    Kaur H; Borhany M; Azzam H; Costa-Lima C; Ozelo M; Othman M
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):589-93. PubMed ID: 27100304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on pediatric bleeding disorders: bleeding scores, benign joint hypermobility, and platelet function testing in the evaluation of the child with bleeding symptoms.
    O'Brien SH
    Am J Hematol; 2012 May; 87 Suppl 1():S40-4. PubMed ID: 22460356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC.
    Gresele P; Falcinelli E; Bury L; Alessi MC; Guglielmini G; Falaise C; Podda G; Fiore M; Mazziotta F; Sevivas T; Bermejo N; De Candia E; Chitlur M; Lambert MP; Barcella L; Glembotsky AC; Lordkipanidzé M
    Res Pract Thromb Haemost; 2024 Jan; 8(1):102305. PubMed ID: 38292347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.
    Deforest M; Grabell J; Albert S; Young J; Tuttle A; Hopman WM; James PD
    Haemophilia; 2015 Sep; 21(5):e384-8. PubMed ID: 26179127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments.
    Hayward CP; Pai M; Liu Y; Moffat KA; Seecharan J; Webert KE; Cook RJ; Heddle NM
    J Thromb Haemost; 2009 Apr; 7(4):676-84. PubMed ID: 19143930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders.
    Dovlatova N; Lordkipanidzé M; Lowe GC; Dawood B; May J; Heptinstall S; Watson SP; Fox SC;
    J Thromb Haemost; 2014 May; 12(5):660-5. PubMed ID: 24618131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited disorders of platelet function.
    Matthews DC
    Pediatr Clin North Am; 2013 Dec; 60(6):1475-88. PubMed ID: 24237983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prothrombin consumption as an indicator of hemorrhagic phenotype in mild platelet function disorders.
    Babuty A; Debord C; Drillaud N; Eveillard M; Trossaert M; Ternisien C; Sigaud M; Cador E; Béné MC; Fouassier M
    Eur J Haematol; 2023 Nov; 111(5):787-795. PubMed ID: 37553915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?
    Castilloux JF; Moffat KA; Liu Y; Seecharan J; Pai M; Hayward CP
    Thromb Haemost; 2011 Oct; 106(4):675-82. PubMed ID: 21947061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status and future prospects for platelet function testing in the diagnosis of inherited bleeding disorders.
    Dovlatova N
    Br J Haematol; 2015 Jul; 170(2):150-61. PubMed ID: 25920378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice.
    Bidlingmaier C; Grote V; Budde U; Olivieri M; Kurnik K
    J Thromb Haemost; 2012 Jul; 10(7):1335-41. PubMed ID: 22578063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ISTH-BAT score and outcomes after endometrial ablation in women with heavy menstrual bleeding.
    Eising HP; Punt MC; Schermer T; Leemans JC; Bongers MY
    Haemophilia; 2023 Nov; 29(6):1573-1579. PubMed ID: 37758646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation.
    Tosetto A; Castaman G; Plug I; Rodeghiero F; Eikenboom J
    J Thromb Haemost; 2011 Jun; 9(6):1143-8. PubMed ID: 21435168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay.
    Lordkipanidzé M; Lowe GC; Kirkby NS; Chan MV; Lundberg MH; Morgan NV; Bem D; Nisar SP; Leo VC; Jones ML; Mundell SJ; Daly ME; Mumford AD; Warner TD; Watson SP;
    Blood; 2014 Feb; 123(8):e11-22. PubMed ID: 24408324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PFA-100 system: a new method for assessment of platelet dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.